Sekėjai

Ieškoti šiame dienoraštyje

2026 m. lapkričio 19 d., ketvirtadienis

The Secret to "Eternal" Youth


„To learn how not to age, one must first understand what aging actually is. Yet, even this is not entirely straightforward. At a recent major scientific congress, participants were asked to define the term—and ended up providing over thirty different definitions.

 

For a long time, the scientific community was divided between two competing theories. Some argued that the aging and death of living organisms are genetically programmed—and perhaps even advantageous to a species, as they free up resources for offspring and accelerate the turnover of generations. Others maintained that this phenomenon is merely a side effect of life, with no "self-destruct program" in existence. In this view, an organism simply sustains constant damage—through the accumulation of mutations, oxidative stress, and errors in biological molecules—eventually reaching a point where it can no longer keep up with the necessary repairs.

 

This debate did not end with the victory of one theory over the other, but rather with their synthesis. Most scientists today believe that aging involves both genetically encoded mechanisms and the gradual accumulation of random damage. Simply put, how long you live depends not only on your genes but also on your lifestyle.

 

While the lifestyle aspect is relatively clear—involving the abandonment of harmful habits, increased physical activity, and social engagement—the biology of aging is far more complex. For instance, scientists are currently testing "geroprotectors"—substances designed to slow aging by targeting specific biological mechanisms. To date, however, none have proven effective in slowing the aging process in humans.

 

Regenerative medicine offers a somewhat different approach. Although it is a relatively young field, its core principles—centered on the cellular mechanisms of tissue repair—were established long ago. Experts in this field link aging to a diminished capacity of organs and tissues to recover—that is, to regenerate—following damage. There would be no life without regeneration; when regeneration ceases, the life of an organism comes to an end.

 

Specialists in regenerative medicine draw a clear distinction between two processes: the aging of an organism and cellular senescence. The decline of an individual cell is not inherently dangerous—in fact, it is necessary. Most cells have a short lifespan, and as long as the mechanism for replacing cells that have aged or lost their normal function remains operational, all is well. The aging of an organism begins when this mechanism breaks down.

 

Why does this happen? In a healthy organism, senescence serves as a protective mechanism—an alarm signal triggered by damage, effectively saying, "Do something!"

 

Research from the 2010s demonstrated that removing cells in the early stages of senescence actually impairs tissue healing. This signal is evolutionarily essential for initiating recovery processes.

 

However, in advanced senescence, a cell stops dividing and loses the ability to renew its own components. Most critically, its secretory phenotype changes—meaning the set of substances it releases to interact with neighboring cells is altered. Such a cell essentially tells its neighbors, "Age just like I am." Consequently, the process spreads. Furthermore, senescent cells gradually learn to evade the immune system, which is otherwise tasked with destroying them.

 

The accumulation of these cells shifts the body into a state of chronic inflammation. A person may remain unaware of this for a long time, until it manifests as a specific disease. For instance, chronic inflammation within adipose (fat) tissue can contribute to the development of obesity. Individuals will, of course, eventually notice a problem, but it may be preceded by a five- to ten-year period during which dysfunctional cells accumulate. Another potential consequence is fibrosis—the replacement of healthy tissue with scar tissue. Fibrosis in vital organs is particularly dangerous and, in severe cases, can be fatal.

 

Restoring the capacity of tissues to renew and regenerate is our primary objective, Our guiding principle is this: the longer tissues retain their ability to regenerate properly and clear away aging cells, the longer a person remains young—perhaps not in terms of chronological age, but biologically.

 

Our work focuses on stem cells and mesenchymal stromal cells (MSCs). (Mesenchymal refers to cells or tissues derived from the mesenchyme—an embryonic connective tissue that develops into connective tissue, blood vessels, lymphatic tissue, bone, cartilage, and muscle.)

 

Stem cells serve as a kind of "reserve" for the body; they have not yet become highly specialized.

 

They possess two key properties: the ability to divide repeatedly while maintaining their own population (self-renewal), and the capacity to transform into specialized cells—such as fat, bone, skin, or muscle cells (differentiation).

 

While MSCs are sometimes referred to as stem cells, true stem cells make up less than 1% of the MSC population. The majority of MSCs act as "efficient managers": they send essential signals to stem cells and regulate  the process of tissue repair.

 

Both stem cells and stromal cells reside in specialized niches—complex microenvironments that allow stem cells to maintain their intrinsic properties and, in the event of injury, differentiate into the specific cell types required.

 

 As an organism ages, both these niches and the stem cells they harbor also undergo aging. The signaling systems become disrupted, and the condition of the cellular components within the niche deteriorates. Compounding this is chronic inflammation, fueled by the accumulation of senescent (aging) cells within the tissues.

 

Niches can be restored through the introduction of exogenous mesenchymal stromal cells (MSCs) or their "secretome"—a complex array of molecules that stromal cells use to orchestrate repair processes. The secretome is multifunctional; among other components, it contains specific proteins that facilitate the renewal of niches. Introducing the secretome helps restore the niche’s structure, its signaling systems, and the function of its supporting cells. Ultimately, this restores the most critical element: stem cell function, and with it, the tissue’s regenerative potential.

 

Furthermore, in informal discussions at scientific forums, a question is increasingly being raised: could aging be an evolutionarily developed defense mechanism against certain threats? If we actively intervene in this process, might we inadvertently compromise its protective function?

 

What kind of threats are we talking about? Primarily, malignant tumors. Aggressively removing senescent cells could potentially increase the risk of developing cancer. Another threat involves physical trauma; in older age, injuries heal much more slowly. Age-related "frailty"—a decline in mobility and physical capacity—is also considered a potential protective mechanism, even though it is associated with an increased risk of various diseases. For instance, if one were to artificially restore muscle strength while the bones and joints remained unprepared for the increased load, the result could be even greater harm. Therefore, aging should be viewed from an evolutionary perspective, and any intervention must be comprehensive—a principle also embraced by regenerative medicine. The first step involves using personalized cellular models to identify which specific repair mechanisms have become impaired in particular tissues, followed by restoring their function. Another approach is not to destroy aging cells, but rather to alter the signals they send to neighboring cells. This can be achieved through "senomorphic" agents or by using the secretome (the set of secreted molecules) derived from mesenchymal stem cells (MSCs) of young donors. Such an approach might not grant eternal youth, but it could extend the period during which organs and tissues retain their functional capacity.

 

Another promising avenue is partial cellular reprogramming. This involves introducing specific genes—known as "Yamanaka factors"—that briefly "roll back" the settings governing gene activity to a more youthful state. Over the next decade, it will become clear whether this approach faces significant limitations—primarily regarding safety—or if it will enable the development of a new class of therapies designed to "rejuvenate" tissues and the entire organism.

 

Finally, we are likely to gain a deeper understanding of the architecture of aging tissues. This has proven challenging, as their structure has turned out to be far more complex than previously assumed. Each tissue contains a multitude of cell types, with individual cells capable of existing in dozens of distinct states. However, the rapid advancement of artificial intelligence will accelerate the analysis of data collected by medical professionals and scientists. I am hopeful that by the end of the decade, we will have a fundamentally new understanding of how tissues age—and how to restore their youth, defined as the ability to function optimally and regenerate.“

 

Aging is the primary risk factor for cancer. Perhaps by optimizing regenerative processes, it will be possible to reduce the risk of cancer—though many currently fear that these risks might actually increase. Future clinical trials will provide the answer. 

 


Komentarų nėra: